Information

Coronavirus (COVID-19) vaccine - Comirnaty® (mRNA Vaccine, Pfizer/BioNTech): national protocol

Protocol guidance Comirnaty® (COVID-19 mRNA Vaccine, Pfizer/BioNTech).


5. Clinical condition or situation to which this Protocol applies

Comirnaty® (COVID-19 mRNA Vaccine, Pfizer/BioNTech) is indicated for active immunisation against COVID-19 disease caused by SARS-CoV-2 virus in accordance with Scottish Government COVID-19 immunisation programme and recommendations given in Chapter 14a of the Immunisation Against Infectious Disease: COVID-19: the green book, chapter 14a - GOV.UK (www.gov.uk) and Scottish Government CMO letters relating to COVID-19 vaccination.

Contact

Email: CEU@gov.scot

Back to top